Pulmonary edema and respiratory failure associated with clenbuterol exposure

American Journal of Emergency Medicine

Volumn 25, Issue 6, 2007, Pages 735.e1-735.e3

  Schechter, Elissa ^a   Hoffman, Robert S ^b   Stajic, Marina ^c   McGee, Michael P ^c   Cuevas, Sonia ^c   Tarabar, Asim ^d  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Forensic Toxicology Laboratory   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; CLENBUTEROL; HALOPERIDOL; LORAZEPAM;

ADULT; AGITATION; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG EXPOSURE; DRUG INTOXICATION; ELECTROCARDIOGRAM; EMERGENCY CARE; HEADACHE; HUMAN; INTOXICATION; INTUBATION; LUNG EDEMA; MALE; NAUSEA AND VOMITING; PLEURA EFFUSION; PRIORITY JOURNAL; RESPIRATORY FAILURE; TACHYCARDIA; THORAX PAIN; TREMOR; ULTRASOUND;

EID: 34250791480     PISSN: 07356757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajem.2006.12.022     Document Type: Article

References (13)

1. Update on illegal compounding of clenbuterol veterinary drug products, in US Food and Drug Administration, Center for Veterinary Medicine, 2002.
2. Prezelj A., Obreza A., and Pecar S. Abuse of clenbuterol and its detection. Curr Med Chem 10 4 (2003) 281-290
3. Hoffman R., et al. Clenbuterol ingestion causing prolonged tachycardia, hypokalemia, and hypophosphatemia with confirmation by quantitative levels. J Toxicol Clin Toxicol 39 4 (2001) 339
4. Barbosa J., et al. Food poisoning by clenbuterol in Portugal. Food Addit Contam 22 6 (2005) 563-566
5. Martinez-Navarro J.F. Food poisoning related to consumption of illicit [beta]-agonist in liver. Lancet 336 8726 (1990) 1311
6. Brambilla G., Cenci T., Franconi F., et al. Clinical and pharmacological profile in a clenbuterol epidemic poisoning of contaminated beef meat in Italy. Toxicol Lett 114 (2000) 147-153
7. Centers for Disease Control. Atypical reactions associated with heroin use-five states, January-April 2005. MMWR Morb Mortal Wkly Rep 54 32 (2005) 793-796
8. Hoffman R.S., Burkhart K., Chan G., Ford M., Ginsburg B., Hahn I., et al. Multistate outbreak of clenbuterol contaminated heroin and cocaine. J Toxicol Clin Toxicol 43 6 (2005) 683-684
9. Goldstein D.R., et al. Clenbuterol and anabolic steroids: a previously unreported cause of myocardial infarction with normal coronary arteriograms. South Med J 91 8 (1998) 780
10. Kierzkowska B., Stanczyk J., and Kasprzak J.D. Myocardial infarction in a 17-year-old body builder using clenbuterol. Circ J 69 (2005) 1144-1146
11. De La Chapelle A., Benoit S., Bouregba M., et al. The treatment of severe pulmonary edema induced by beta adrenergic agonist tocolytic therapy with continuous positive airway pressure delivered by face mask. Anesth Analg 94 (2002) 1593-1594
12. Pisani R.J., and Rosenow III E.C. Pulmonary edema associated with tocolytic therapy. Ann Intern Med 110 9 (1989) 714-718
13. Leduc D., et al. Severe pulmonary edema associated with tocolytic therapy. Intensive Care Med 22 (1996) 1280-1281